Skip to main content
NeuronFeed

Evvy · Series B

Pioneering precision care for vaginal health through advanced microbiome testing and personalised treatment plans.

Amount

$40M

Round

Series B

Valuation

—

Announced

Sep 2026

Investors

Notes

auto-discovered via firecrawl

📎 Source